Rivista

AntiemeticProphylaxis with NEPA (NETUPITANT/PALONOSETRON) and Dexamethasone to PreventChemotherapy-Induced Nausea and Vomiting (CINV) in Hodgkin’SLymphoma Naïve PatientsReceiving ABVD Regimen: A MulticenterPhaseIia Study

Autori: Daniela Nasso,Silvia Bolis, Elisabetta Abbruzzese, Ilaria Romano,Ida Provenzano Cristiano Tesei,Ida Provenzano, Maria Cantonetti

Data: 2020

Ambito di interesse: Ematologia

Rivista: Blood

Potrebbero interessarti anche:

Rivista 2,576

New approaches to treating type 2 diabetes mellitus in the elderly: role of incretin therapies

Autori: Abbatecola AM, Maggi S, Paolisso G.

Data: 2008

Ambito di interesse: farmacologia, invecchiamento

Rivista: Drugs Aging

Leggi dettagli

Rivista 5,1

Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors

Autori: Benedetta Stefanini et al

Data: 22 nov 2023

Ambito di interesse: epatologico

Rivista: Dig Liver Dis

Leggi dettagli

Rivista 3,804

Mediterranean diet and mobility decline in older persons.

Autori: Milaneschi Y, Bandinelli S, Corsi AM, Lauretani F, Paolisso G, Dominguez LJ, Semba RD, Tanaka T, Abbatecola AM, Talegawkar SA, Guralnik JM, Ferrucci L.

Data: 2010

Ambito di interesse: invecchiamento, geriatria

Rivista: Exp Gerontol

Leggi dettagli

AntiemeticProphylaxis with NEPA (NETUPITANT/PALONOSETRON) and Dexamethasone to PreventChemotherapy-Induced Nausea and Vomiting (CINV) in Hodgkin’SLymphoma Naïve PatientsReceiving ABVD Regimen: A MulticenterPhaseIia Study

Potrebbero interessarti anche:

New approaches to treating type 2 diabetes mellitus in the elderly: role of incretin therapies

Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors

Mediterranean diet and mobility decline in older persons.

Cosa fare per

Security Verification